Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP770043.RAsNExDPXOX6x25EDORbfKKFOpTw8avpk2FNi4PZRcyeI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP770043.RAsNExDPXOX6x25EDORbfKKFOpTw8avpk2FNi4PZRcyeI130_assertion type Assertion NP770043.RAsNExDPXOX6x25EDORbfKKFOpTw8avpk2FNi4PZRcyeI130_head.
- NP770043.RAsNExDPXOX6x25EDORbfKKFOpTw8avpk2FNi4PZRcyeI130_assertion description "[Since 5-10% of transitional cell carcinomas (TCCs) have been shown to contain a mutated HRAS gene, and protein expression levels of all forms of HRAS have been correlated with TCC progression, we chose to study the contribution of the HRAS oncogene in bladder tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP770043.RAsNExDPXOX6x25EDORbfKKFOpTw8avpk2FNi4PZRcyeI130_provenance.
- NP770043.RAsNExDPXOX6x25EDORbfKKFOpTw8avpk2FNi4PZRcyeI130_assertion evidence source_evidence_literature NP770043.RAsNExDPXOX6x25EDORbfKKFOpTw8avpk2FNi4PZRcyeI130_provenance.
- NP770043.RAsNExDPXOX6x25EDORbfKKFOpTw8avpk2FNi4PZRcyeI130_assertion SIO_000772 2247480 NP770043.RAsNExDPXOX6x25EDORbfKKFOpTw8avpk2FNi4PZRcyeI130_provenance.
- NP770043.RAsNExDPXOX6x25EDORbfKKFOpTw8avpk2FNi4PZRcyeI130_assertion wasDerivedFrom befree-20140225 NP770043.RAsNExDPXOX6x25EDORbfKKFOpTw8avpk2FNi4PZRcyeI130_provenance.
- NP770043.RAsNExDPXOX6x25EDORbfKKFOpTw8avpk2FNi4PZRcyeI130_assertion wasGeneratedBy ECO_0000203 NP770043.RAsNExDPXOX6x25EDORbfKKFOpTw8avpk2FNi4PZRcyeI130_provenance.